Bioxytran, Inc.

BIXT · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$283$35-$1,354-$512
Dep. & Amort.$4$3$2$3
Deferred Tax$0$0$0$0
Stock-Based Comp.$38$42$27$229
Change in WC-$499$147$353$86
Other Non-Cash$699-$307$805$237
Operating Cash Flow-$41-$81-$167$42
Investing Activities
PP&E Inv.$15-$15-$0-$10
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$17$0$0$0
Investing Cash Flow-$2-$15-$0-$10
Financing Activities
Debt Repay.$0$95$167-$62
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$55$0$0$0
Financing Cash Flow$55$95$167-$62
Forex Effect$0$0$0$0
Net Chg. in Cash$11-$1-$1-$30
Supplemental Information
Beg. Cash$3$4$5$35
End Cash$14$3$4$5
Free Cash Flow-$26-$96-$167$32